K080247 is an FDA 510(k) clearance for the QUIKCLOT NOSEBLEED. Classified as Splint, Intranasal Septal (product code LYA), Class I - General Controls.
Submitted by Z-Medica Corporation (Wallingford, US). The FDA issued a Cleared decision on February 27, 2008 after a review of 27 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 874.4780 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Z-Medica Corporation devices